Gamida Cell to Report Third Quarter 2023 Financial Results

Rhea-AI Summary

Gamida Cell Ltd. will release its financial results for Q3 2023 on November 14, 2023. The company will also provide business updates and host a conference call and live webcast to discuss the financial results and answer questions. Conference call details: Date/Time: November 14, 2023 at 8:30 AM Eastern Time. Domestic dial-in: 1-877-425-9470. International dial-in: 1-201-389-0878. Conference ID: 13741024. Webcast replay will be available on the company's website for approximately 30 days.

BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that the company will release its financial results for the third quarter ended September 30, 2023 and provide an update on the company on Tuesday, November 14, 2023.

Following the release, management will host a conference call and live webcast at 8:30 am Eastern Time to discuss the financial results, provide business updates and answer questions.

Conference Call Dial-In & Webcast Information:

	Date/Time:	Tuesday, November 14, 2023 at 8:30 AM Eastern Time
	Domestic:	1-877-425-9470
	International:	1-201-389-0878
	Conference ID:	13741024
	Call me™:	Click here.
	Webcast:	Click here.

A replay of the webcast will be available on the Company’s website. approximately two hours after the event, for approximately 30 days.

About Gamida Cell

Gamida Cell is a cell therapy pioneer working to turn cells into powerful therapeutics. The company’s proprietary nicotinamide (NAM) technology leverages the properties of NAM to enhance and expand cells, creating allogeneic cell therapy products and candidates that are potentially curative for patients with hematologic malignancies. These include Omisirge™ (omidubicel-onlv), an FDA-approved nicotinamide modified allogeneic hematopoietic progenitor cell therapy for patients with hematologic malignancies, and GDA-201, an intrinsic NK cell therapy candidate being investigated for the treatment of patients with non-Hodgkin lymphoma. For additional information, please visit www.gamida-cell.com or follow GamidaCell on LinkedIn, X, Facebook or Instagram.

Omisirge™ is a trademark of Gamida Cell Inc. © 2023 Gamida Cell Inc. All Rights Reserved.

Investor Contacts:
Chuck Padala
LifeSci Advisors
chuck@lifesciadvisors.com
1-646-627-8390

Media Contact:
Dan Boyle
Orangefiery
media@orangefiery.com
1-818-209-1692

FAQ

When will Gamida Cell release its financial results for Q3 2023?

Gamida Cell will release its financial results for Q3 2023 on Tuesday, November 14, 2023.

What updates will Gamida Cell provide along with the financial results?

Gamida Cell will provide business updates along with the financial results.

When is the conference call and live webcast scheduled?

The conference call and live webcast are scheduled for Tuesday, November 14, 2023 at 8:30 AM Eastern Time.

What are the dial-in details for the conference call?

Domestic dial-in: 1-877-425-9470. International dial-in: 1-201-389-0878. Conference ID: 13741024.

Will there be a replay of the webcast?

Yes, a replay of the webcast will be available on the company's website for approximately 30 days.